Search

everythinglearnresearchcommunity

for

Search:↓

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Immunotherapy can help treat severe alopecia areata.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Alopecia areata involves unique activation of certain immune cells.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Targeted immune modulation can help achieve stable remission in alopecia areata.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Two-photon microscopy improves skin imaging but faces safety and cost challenges for clinical use.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

Enhancing Tregs can protect against alopecia areata.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Hydrogel scaffolds can help wounds heal better and grow hair.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Artificial skin grafts face immune rejection, but stem cells may improve future designs.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Immunofluorescence tomography is a cost-effective method for creating detailed 3-D images of tissues.

Intradermal testing can better detect corticosteroid allergies than patch testing.